MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, F. S.
Right arrow Articles by Farb, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, F. S.
Right arrow Articles by Farb, D. H.

Inverse modulation of gamma-aminobutyric acid- and glycine-induced currents by progesterone

FS Wu, TT Gibbs and DH Farb

Department of Anatomy and Cell Biology, State University of New York, Health Science Center, Brooklyn 11203.

The ability of certain synthetic and endogenous steroids to modulate neuronal responses to gamma-aminobutyric acid (GABA) is well documented, but little is known of the effect of steroids on glycine responses. We show here that in voltage-clamped neurons progesterone (10-100 microM) itself enhances GABA-induced chloride currents but, surprisingly, antagonizes those induced by glycine. Some, but not all, progesterone metabolites also display these effects. The effects of progesterone on GABA and glycine responses are dose dependent, with EC50 values of 26 and 16 microM and maxima of +156 and -60%, respectively. Progesterone and its reduced metabolite 5 alpha-pregnan-3 alpha-ol-20-one potentiate GABA responses by acting through a common site. The site through which progesterone acts to inhibit glycine responses is distinct from the strychnine and glycine binding sites. These results not only provide an important distinction between chloride-mediated GABA and glycine responses but also suggest that endogenous progesterone or its metabolites may differentially modulate the inhibitory actions of these two neurotransmitters.

Volume 37, Issue 5, pp. 597-602, 05/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
G. Sadri-Vakili, G. C. Janis, R. C. Pierce, T. T. Gibbs, and D. H. Farb
Nanomolar Concentrations of Pregnenolone Sulfate Enhance Striatal Dopamine Overflow in Vivo
J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 840 - 845.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. El-Etr, Y. Akwa, E.-E. Baulieu, and M. Schumacher
The Neuroactive Steroid Pregnenolone Sulfate Stimulates the Release of Gonadotropin-Releasing Hormone from GT1-7 Hypothalamic Neurons, through N-Methyl-D-Aspartate Receptors
Endocrinology, June 1, 2006; 147(6): 2737 - 2743.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S.-C. Chen, T.-J. Chang, and F.-S. Wu
Competitive Inhibition of the Capsaicin Receptor-Mediated Current by Dehydroepiandrosterone in Rat Dorsal Root Ganglion Neurons
J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 529 - 536.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. W. Lynch
Molecular Structure and Function of the Glycine Receptor Chloride Channel
Physiol Rev, October 1, 2004; 84(4): 1051 - 1095.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
C. J. Weir, A. T. Y. Ling, D. Belelli, J. A. W. Wildsmith, J. A. Peters, and J. J. Lambert
The interaction of anaesthetic steroids with recombinant glycine and GABAA receptors{dagger}
Br. J. Anaesth., May 1, 2004; 92(5): 704 - 711.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. M. LOSEL, E. FALKENSTEIN, M. FEURING, A. SCHULTZ, H.-C. TILLMANN, K. ROSSOL-HASEROTH, and M. WEHLING
Nongenomic Steroid Action: Controversies, Questions, and Answers
Physiol Rev, July 1, 2003; 83(3): 965 - 1016.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. Romieu, R. Martin-Fardon, W. D. Bowen, and T. Maurice
sigma 1 Receptor-Related Neuroactive Steroids Modulate Cocaine-Induced Reward
J. Neurosci., May 1, 2003; 23(9): 3572 - 3576.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. K. Singh, B. D. Schultz, J. A. Katzenellenbogen, E. M. Price, R. J. Bridges, and N. A. Bradbury
Estrogen Inhibition of Cystic Fibrosis Transmembrane Conductance Regulator-Mediated Chloride Secretion
J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 195 - 204.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
K. Paradiso, K. Sabey, A. S. Evers, C. F. Zorumski, D. F. Covey, and J. H. Steinbach
Steroid Inhibition of Rat Neuronal Nicotinic alpha 4beta 2 Receptors Expressed in HEK 293 Cells
Mol. Pharmacol., August 1, 2000; 58(2): 341 - 351.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
P. Follesa, M. Serra, E. Cagetti, M. G. Pisu, S. Porta, S. Floris, F. Massa, E. Sanna, and G. Biggio
Allopregnanolone Synthesis in Cerebellar Granule Cells: Roles in Regulation of GABAA Receptor Expression and Function during Progesterone Treatment and Withdrawal
Mol. Pharmacol., June 1, 2000; 57(6): 1262 - 1270.
[Abstract] [Full Text]


Home page
J. Neurophysiol.Home page
D. Haage and S. Johansson
Neurosteroid Modulation of Synaptic and GABA-Evoked Currents in Neurons From the Rat Medial Preoptic Nucleus
J Neurophysiol, July 1, 1999; 82(1): 143 - 151.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. P. Blanton, Y. Xie, L. J. Dangott, and Jonathan. B. Cohen
The Steroid Promegestone Is a Noncompetitive Antagonist of the Torpedo Nicotinic Acetylcholine Receptor that Interacts with the Lipid-Protein Interface
Mol. Pharmacol., February 1, 1999; 55(2): 269 - 278.
[Abstract] [Full Text]


Home page
JEMHome page
G. R. Ehring, H. H. Kerschbaum, C. Eder, A. L. Neben, C. M. Fanger, R. M. Khoury, P. A. Negulescu, and M. D. Cahalan
A Nongenomic Mechanism for Progesterone-mediated Immunosuppression: Inhibition of K+ Channels, Ca2+ Signaling, and Gene Expression in T Lymphocytes
J. Exp. Med., November 2, 1998; 188(9): 1593 - 1602.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. H. R. Wetzel, B. Hermann, C. Behl, E. Pestel, G. Rammes, W. Zieglgänsberger, F. Holsboer, and R. Rupprecht
Functional Antagonism of Gonadal Steroids at the 5-Hydroxytryptamine Type 3 Receptor
Mol. Endocrinol., September 1, 1998; 12(9): 1441 - 1451.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Beekman, J. T. Ungard, M. Gasior, R. B. Carter, D. Dijkstra, S. R. Goldberg, and J. M. Witkin
Reversal of Behavioral Effects of Pentylenetetrazol by the Neuroactive Steroid Ganaxolone
J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 868 - 877.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. Park-Chung, F.-S. Wu, R. H. Purdy, A. A. Malayev, T. T. Gibbs, and D. H. Farb
Distinct Sites for Inverse Modulation of N-Methyl-D-Aspartate Receptors by Sulfated Steroids
Mol. Pharmacol., December 1, 1997; 52(6): 1113 - 1123.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics